SIG Stock Overview
Engages in the wholesale distribution of pharmaceutical goods and medical consumables to community pharmacies primarily in Australia. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Sigma Healthcare Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$2.64 |
| 52 Week High | AU$3.01 |
| 52 Week Low | AU$0.91 |
| Beta | 0.14 |
| 1 Month Change | 0.38% |
| 3 Month Change | 88.57% |
| 1 Year Change | 168.02% |
| 3 Year Change | 450.00% |
| 5 Year Change | 355.17% |
| Change since IPO | -9.90% |
Recent News & Updates
Recent updates
Sigma Healthcare Limited's (ASX:SIG) Subdued P/S Might Signal An Opportunity
Feb 24
Is There An Opportunity With Sigma Healthcare Limited's (ASX:SIG) 49% Undervaluation?
Jan 05Sigma Healthcare (ASX:SIG) Will Pay A Dividend Of AU$0.01
Mar 31Some Investors May Be Worried About Sigma Healthcare's (ASX:SIG) Returns On Capital
Dec 08The Returns On Capital At Sigma Healthcare (ASX:SIG) Don't Inspire Confidence
May 11Shareholders Shouldn’t Be Too Comfortable With Sigma Healthcare's (ASX:SIG) Strong Earnings
Mar 29Sigma Healthcare Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Mar 24How Many Sigma Healthcare Limited (ASX:SIG) Shares Do Institutions Own?
Feb 16We Think Sigma Healthcare (ASX:SIG) Has A Fair Chunk Of Debt
Jan 19What Type Of Returns Would Sigma Healthcare's(ASX:SIG) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?
Dec 31Are Insiders Buying Sigma Healthcare Limited (ASX:SIG) Stock?
Dec 13Shareholder Returns
| SIG | AU Healthcare | AU Market | |
|---|---|---|---|
| 7D | -2.6% | -2.9% | -1.0% |
| 1Y | 168.0% | -6.3% | 8.5% |
Return vs Industry: SIG exceeded the Australian Healthcare industry which returned -6.3% over the past year.
Return vs Market: SIG exceeded the Australian Market which returned 8.5% over the past year.
Price Volatility
| SIG volatility | |
|---|---|
| SIG Average Weekly Movement | 10.8% |
| Healthcare Industry Average Movement | 5.4% |
| Market Average Movement | 8.0% |
| 10% most volatile stocks in AU Market | 16.7% |
| 10% least volatile stocks in AU Market | 3.1% |
Stable Share Price: SIG has not had significant price volatility in the past 3 months compared to the Australian market.
Volatility Over Time: SIG's weekly volatility (11%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1912 | n/a | Vikesh Ramsunder | www.sigmahealthcare.com.au |
Sigma Healthcare Limited, together with its subsidiaries, engages in the wholesale distribution of pharmaceutical goods and medical consumables to community pharmacies primarily in Australia. The company operates various aligned pharmacies, including branded pharmacies under the Amcal, Discount Drug Stores, Guardian, and PharmaSave brands. It also provides retail support services to its branded network of pharmacy members; dose administration aid services; and third and fourth-party logistics services to pharmaceutical manufacturers and other supplier partners.
Sigma Healthcare Limited Fundamentals Summary
| SIG fundamental statistics | |
|---|---|
| Market cap | AU$4.15b |
| Earnings (TTM) | -AU$3.00m |
| Revenue (TTM) | AU$3.48b |
1.2x
P/S Ratio-1,381x
P/E RatioIs SIG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SIG income statement (TTM) | |
|---|---|
| Revenue | AU$3.48b |
| Cost of Revenue | AU$3.25b |
| Gross Profit | AU$227.81m |
| Other Expenses | AU$230.81m |
| Earnings | -AU$3.00m |
Last Reported Earnings
Jul 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0019 |
| Gross Margin | 6.55% |
| Net Profit Margin | -0.086% |
| Debt/Equity Ratio | 0% |
How did SIG perform over the long term?
See historical performance and comparisonDividends
0.4%
Current Dividend Yield-481%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/25 13:34 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/07/31 |
| Annual Earnings | 2024/01/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Sigma Healthcare Limited is covered by 24 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| John Hester | ANZ Equities Pty Limited |
| Dennis Hulme | APP Securities Pty Ltd. |
| Russell Wright | Barclay Pearce Capital Pty Limited |